CarloSalvatoreContoreggiMD

PubMed

• 3 citations
  Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?
  Carlo Contoreggi, George P. Chrousos, Michele Di Mascio
  Neurobehavioral HIV Medicine. 2016-12-28
• 11 citations
  Corticotropin Releasing Hormone and Imaging, Rethinking the Stress Axis
  Carlo Contoreggi
  Nuclear Medicine and Biology. 2015-04-01
• 33 citations
  Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.
  Hiroto Kuwabara, Stephen J. Heishman, James Robert Brašić, Carlo Contoreggi, Nicola G. Cascella
  Plos One. 2014-12-10

Journal Articles

• Corticotropin releasing hormone and imaging, rethinking the stress axis  
  Contoreggi C, Nucl Med Biol, 1/1/2014
• [76Br]BMK-152, a nonpeptide analogue, with high affinity and low nonspecific binding for the corticotropin-releasing factor type 1 receptor  
  Jagoda EM, Lang L, Contoreggi C, McCullough K, Kim BM, Ma Y, Rice KC, Szajek LP, Eckelman WC, Kiesewetter DO, Synapse, 1/1/2011
• Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotrophin-releasing hormone receptor antagonist  
  Horn TL, Harder JB, Johnson WD, Curry PT, Parchment RE, Morrissey RL, Mellick PW, Calis KA, Gold PW, Rice KC, Contoreggi C, Charney DS, Cizza G, Glaze ER, Tomaszewski ..., Toxicology, 4/9/2008
• Subchronic Oral Toxcity Of The Corticotropin-releasing hormone (CRH) receptor antagonist, Antalarmin, In Rhesus Monkeys  
  Johnson WD, Harder JB, McCormick DL, Detrisac CJ, Calis K, Gold PW, Rice K, Manji H, Kunos, Heilig M, Contoreggi C, Vocci F, Kling M, Winslow J, Chrousos Glaze ER ..., Toxicology, 1/13/2008
• Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify “connectivity constellation: and drug target genes with p...  
  Uhl GR, Drgon T, Johnson C, Li CY, Contoreggi C, Hess J, Naiman D, Liu QR, Ann NY Acad Sci, 1/1/2008
• Effects of Long-term Food Restriction and Aging on Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) in Obese (fa/fa) and Lean Zucker Rats  
  Michaelides M, Davis LM, Pei Z, Cheskin LJ, Watkins PA, Moran T, Contoreggi C, Wang GJ, Volkow ND, Thanos PK, Obesity, 1/1/2007
• Bromocriptine Reduces Hyperphagia and Adiposity in (fa/fa) Zucker and Diet-Induced Obese Rats through Selective Changes in Dopamine (DA) D2 receptor (D2R) and DA Trans...  
  Davis LM, Michaelides M, Cheskin LJ, Moran T, Watkins PA, Pei Z, Contoreggi C, Wang GJ, Volkow ND, Thanos PK, Obesity, 1/1/2007
• “Higher order” addiction molecular genetics: Convergent data from genome-wide association in humans and mice  
  Uhl GR, Drgon T, Johnson C, Fatusin OO, Liu Q-R, Contoreggi C, Li C-Y, Buck K, Crabbe J, Biochemical Pharmacology, 1/1/2007
• An EHR-Based Multi-Site Recruiting System for Clinical Trials  
  Massoud Vahabzadeh, Jia-Ling Lin, Mustapha Mezghanni, Carlo Contoreggi, and Michelle Leff, Proc 20th IEEE International Symposium on computer-Based Medical systems, 1/1/2007
• Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans  
  Nelson RA, Boyd SJ, Ziegelstein RC , Herning R, Cadet JL, Henningfield JE, Schuster, CR, Contoreggi C, Gorelick DA, Drug and Alcohol Dependence, 1/1/2006
• Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT  
  Jagoda EM. Lang L, Tokugawa J, Simmons A, Ma Y, Contoreggi C, Kiesewetter D, Eckelman WC, Synapse, 1/1/2006
• Risky decision making and the anterior cingulate cortex in abstinent drug abusers and nonusers  
  Fishbein DH, Eldretha DL, Hydeb C, Matochik JA, London ED, Contoreggi C, Kurian V, Kimes AS, Breedena A , Grant S, Cognitive Brain Research, 1/1/2005
• Influence of psychotherapy attendance on buprenorphine treatment outcome  
  Montoya I, Schroeder JR, Preston KL, Covi L, Umbricht A, Contoreggi C, Fudala PJ, Johnson RE , Gorelick DA, Journal of Substance Abuse Treatment, 1/1/2005
• New Tools to Monitor Stress Using Non-Invasive PET Imaging  
  William C. Eckelman, Kenner C. Rice, Carlo Contoreggi, New York Academy of Science, 1/1/2004
• Prefrontal Cortical Dysfunction in Abstinent Cocaine Abusers  
  Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet JL, Kimes A, Funderburk F, London E, Journal of Neuropsychiatry Clinical Neuroscience, 1/1/2004
• Prefrontal Corticol Dysfunction in Abstinent Cocaine Abusers  
  Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet JC, Kimes A, Funderburk F, London E, J Neuropsychiatry Clin Neurosci, Fall, 1/1/2004
• Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence  
  Montoya ID, Gorelick DA, Preston KL, Schroeder JR, Umbricht A, Cheskin LJ, Lange WR, Contoreggi C, Johnson RE, & Fudala PJ, Clinical Pharmacology and Therapeutics, 1/1/2004
• Binding potential image based statistical mapping for detection of dopamine release by [11C]raclopride dynamic PET  
  Zhou Y, Brasic J, Endres CJ, Kuwabara H, Kimes A, Contoreggi C, Maini A, Ernst M, Wong DF, NeuroImage, 1/1/2003
• Treatment Seeking Inpatient Cocaine Abusers Show Hypothalamic Dysregulation of Both Basal Prolactin and Cortisol Secretion  
  Contoreggi C, Herning RI, Koeppl B, Simpson PM, Paulo J. Negro Jr., Fortner-Burton C, Hess J, Neuroendocinology, 1/1/2003
• Audioradiographic visualization of corticotrophin releasing hormone type 1 receptors with a nonpeptide ligand: synthesis of [76Br]MJL-1-109-2  
  Jagoda E, Contoreggi C, Mei-Jing L, Chih-Hao KK, Szajek LP, Listwak S, Gold P, Chrousos G, Greiner E, Kim BM, Jacobson AE, Rice KC, Eckelman W, Journal of Medicinal Chemistry, 1/1/2003
• Synthesis of Doubly 13C-Labelled Antalarmin Isotopomers for Pharmacokinetic Studies  
  Greiner E, Atkinson AJ Jr., Ayala A, Chrousos GP, Contoreggi C, Eckelman WC, Gold PW, Habib KE, Jacobson AE, Webster EL, Rice KC, J Labelled Compounds Radiopharm, 1/1/2003
• PET Imaging Human Brain Nicotinic Acetylcholine Receptors and Whole Body Distribution in Humans  
  Kimes AS, Horti AG, London ED, Chefer SI Contoreggi C, Ernst M, Friello P, Koren AO, Kurian V, Matochik JA, Pavlova O, Vaupel DB, Mukhin AG, FASEB Journal, 1/1/2003
• Stress Hormone Responses to Corticotropin–Releasing Hormone in Substance Abusers without Severe Co-morbid Psychiatric Disease  
  Contoreggi C, Herning RI, Na P, Gold PW, Chrousos G, Negro PJ, Better W, JL Cadet, Biological Psychiatry, 1/1/2003
• Neural substrates of decision-making in adults with attention-deficit hyperactivity disorder  
  Ernst M, Kimes AS, London ED, Matochik JA, Eldreth D, Tata S, Contoreggi C, Leff M, Bolla K, American Journal of Psychiatry, 1/1/2003
• Decision Making in Adolescents With Behavior Disorders and Adults With Substance Abuse  
  Ernst M, Grant SJ, London ED, Contoreggi CS, Kimes AS, Spurgeon L, American Journal of Psychiatry, 1/1/2003
• Join now to see all

Books/Book Chapters

• Current Therapy of Infectious Disease 
  Chapter: Intravenous Drug Abuse: Infectious Risks 
  Page 373 - 377Contoreggi C, Rexroad E, and Lambert JSEditors: Schlossberg D.Mosby, Philadelphia, PAEdition 2nd,2001
• Current Therapy of Infectious Disease 
  Chapter: Intravenous Drug Abuse: Infectious Risks 
  Page 305 - 307Contoreggi C, Rexroad VE, and Lange WREditors: Schlossberg D.Mosby, Philadelphia, PA1996
• Neuroendocrine Regulation of Appetite 
  Chapter: Chapter 13. Scientific Evidence for Musculoskeletal, Bariatric and Sports Nutrition. 
  Page 211 - 229Contoreggi, CEditors: Ingrid Kohlstadt.Kohlstadt I

Abstracts/Posters

• Cocaine-Related Cues Elicit Craving and Activate Cortical Circuits Relevant to Episodic Memory.
  London ED, Grant S, Newlin D, Villemagne V, Phillips R, Liu X, Kimes AS, Contoreggi C, and Margolin A, Biol Psychiatry, 1/1/1996
• Evaluation of an HTLV II risk population with an HTLV-I / HTLV-II combination immunoassay and an HTLV-I-II western immunoblot.
  Robertson E, Stephens J, Chan E, Motley C, Buytendrop M, Prillaman J, Coleman C, Garrett N, Welblan B, Contoreggi C., Hoffman W, and Phelps B, HIV; Sixth International Conference on Human Retrovirology, Absecon, NJ, 1/1/1994

Lectures

• The management of incidental findings in functional imaging research. 
  Kona, HI - 1/1/2009
• Bromocriptine Reduces Hyperphagia and Adiposity in (fa/fa) Zucker and Diet-Induced Obese Rats through Selective Changes in Dopamine (DA) D2 receptor (D2R) and DA Trans... 
  New Orleans, LA - 1/20/2007
• PET imaging with 2-[18F]F-A-85380 showa increased densities of nicotinic receptors in heavy smokers compared to non-smokers. 
  Washington, DC - 1/1/2005
• Development of corticotrophin-releasing hormone type 1 receptor PET ligands Current progress 
  San Diego, CA - 1/1/2004
• In Vitro Receptor Binding Properties of the non-peptide Corticotrophin Releasing Hormone-Type 1 receptor antagonist [76Br] MJL-1-109-2, a Putative Positron Imaging Lig... 
  San Juan, Puerto Rico - 1/1/2002
• Imaging Risk-Taking in Attention-Deficit Hyperactivity Disorder. 
  1/1/2001
• Reduced Cerebral Blood Flow in Anterior Cingulate Cortex (ACC) during Stroop Performance in Chronic Cocaine Users. 
  Brighton, United Kingdom - 1/1/2001
• ADHD: cingulate dysfunction. 
  San Diego, CA - 1/1/2001
• Short-term corticotropin-releasing hormone receptor-1 antagonist, antalarmin treatment down regulates 5-HT2A sites with PET in macaque brain. 
  San Diego, CA - 1/1/2001
• Ligands for PET Imaging of the Corticotrophin Releasing Hormone Type 1 Receptor. 
  College for the Prevention of Drug Dependence, Scottsdale, AZ - 1/1/2001
• The Science of the Placebo: Toward an Interdisciplinary Research Agenda 
  Natcher Conference Center, National Institutes of Health, Bethesda, MD - 1/19/2000
• Corticotrophin Releasing Hormone type -1 receptor 
  Bethesda, MD - 1/16/2000
• Generalized Brain Volumetric Losses in Cushing's Disease. 
  Toronto, Canada - 1/1/2000
• Brain Activation During Performance of a Gambling Task. 
  New Orleans, LA - 1/1/2000
• Corticotropin-releasing hormone antagonist attenuates adjuvant-induced arthritis: evidence supporting major role for CRH in peripheral inflammation. 
  New Orleans, LA - 1/1/2000
• Neural systems and cue-induced cocaine craving. 
  New Orleans, LA - 1/1/2000
• Effects of Triazolam on Brain Activity During Episodic Memory Encoding. 
  San Francisco, CA - 1/1/2000
• Cerebral Blood Flow Changes During a Gambling Task. 
  1/1/2000
• Development of CRF Receptor Antagonist Radioligand for SPECT and PET. 
  1/1/1999
• Drug Abusers Show Impaired Performance on a Test of Orbitofrontal Function 
  Washington, DC - 1/1/1998
• Acute and Chronic Effects of the Non-Peptide Corticotropin-Releasing Hormone (CRH) Antagonist, Antalarmin. 
  1/1/1998
• A Review of Prescription Drugs that Promote Weight Gain: Implications for Treating Obese Patients. 
  San Francisco, CA - 1/6/1997
• Drug Abusers Show Impaired Performance on a Test of Orbitofrontal Function. 
  College for the Prevention of Drug Dependence - 1/1/1997
• Regional Cerebral Glucose Metabolism During Induced Craving for Cocaine: A PET FDG Study 
  1/1/1997
• Metaclopramide-Induced Prolactin Secretion Distinguishes Male Amyotrophic and Primary Lateral Sclerosis Patient Groups from Phenotypically Similar Disorders. 
  San Francisco, CA - 1/23/1996
• Join now to see all